POTASSIUM CITRATE
POTASSIUM CITRATE is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: POTASSIUM CITRATE; Generic name: POTASSIUM CITRATE; Manufacturer: Rising Pharma Holdings, Inc..
| Brand name | POTASSIUM CITRATE |
|---|---|
| Generic name | POTASSIUM CITRATE |
| Manufacturer | Rising Pharma Holdings, Inc. |
| Used for | 1 INDICATIONS & USAGE Potassium citrate is a citrate salt of potassium indicated for the management of: Renal tubular acidosis (RTA) with calcium stones ( 1.1 ) Hypocitraturic calcium oxalate nephrolithiasis of any etiology ( 1.2 ) Uric acid lithiasis with or without calcium stones ( 1.3 ) 1.1 Renal Tubular Acidosis (RTA) with Calcium Stones Potassium citrate is indicated for the management of renal tubular acidosis [see Clinical Studies ( 14.1 )]. 1.2 Hypocitraturic Calcium Oxalate Nephrolithiasis of any Etiology Potassium citrate is indicated for the management of Hypocitraturic calcium oxalate nephrolithiasis [see Clinical Studies ( 14.2 )]. 1.3 Uric Acid Lithiasis with or without Calcium |
| Dosage | 2 DOSAGE & ADMINISTRATION Objective: To restore normal urinary citrate (greater than 320 mg/day and as close to the normal mean of 640 mg/day as possible), and to increase urinary pH to a level of 6.0 to 7.0. Severe hypocitraturia (urinary citrate < 150 mg/day): therapy should be initiated at 60 mEq per day; a dose of 30 mEq two times per day or 20 mEq three times per day with meals or within 30 minutes after meals or bedtime snack ( 2.2 ) Mild to moderate hypocitraturia (urinary citrate >150 mg |
| Active ingredient(s) | POTASSIUM CITRATE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=164d9d05-fbb1-4d99-8ba3-ff9c172aa8ca |